Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Clinical Genitourinary Cancer

Volumn 14, Issue 1, 2016, Pages e59-e65

  Pokuri, Venkata K ^a   Syed, Johar R ^a   Yang, Zhengyu ^a   Field, Erinn P ^a   Cyriac, Susanna ^b   Pili, Roberto ^c   Levine, Ellis Glenn ^a   Azabdaftari, Gissou ^a   Trump, Donald L ^d   Guru, Khurshid ^a   George, Saby ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Inova Comprehensive Cancer and Research Center   (United States)

Author keywords

Complete pathological response; Mixed tumors; Muscle invasive; Neo adjuvant chemotherapy; Predictors; Urothelial carcinoma; Variant histology

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CLINICAL ARTICLE; CYSTECTOMY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYDRONEPHROSIS; MALE; MIXED TUMOR; MUSCLE INVASIVE BLADDER CANCER; PATIENT SELECTION; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84952871261     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.09.013     Document Type: Article

References (35)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
2. M.H. Hussain, D.P. Wood, D.F. Bajorin, and et al. Bladder cancer: narrowing the gap between evidence and practice J Clin Oncol 27 2009 5680 5684
3. M.A. Dall'Era, L. Cheng, and C.X. Pan Contemporary management of muscle-invasive bladder cancer Expert Rev Anticancer Ther 12 2012 941 950
4. A. Stenzl, N.C. Cowan, M. De Santis, and et al. [Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines] Actas Urol Esp 36 2012 449 460
5. R.E. Hautmann, J.E. Gschwend, R.C. de Petriconi, M. Kron, and B.G. Volkmer Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era J Urol 176 2006 486 492
6. J.P. Stein, G. Lieskovsky, R. Cote, and et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
7. H.B. Grossman, R.B. Natale, C.M. Tangen, and et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
8. G. Griffiths, R. Hall, R. Sylvester, D. Raghavan, and M.K. Parmar International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171 2177
9. P.U. Malmstrom, E. Rintala, R. Wahlqvist, P. Hellstrom, S. Hellsten, and E. Hannisdal Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic cystectomy trial I. The Nordic Cooperative Bladder Cancer Study Group J Urol 155 1996 1903 1906
10. International Collaboration of Trialists Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial Lancet 354 1999 533 540
11. A. Sherif, E. Rintala, O. Mestad, and et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2 Scand J Urol Nephrol 36 2002 419 425
12. E. Rintala, E. Hannisdahl, S.D. Fossa, S. Hellsten, and S. Sander Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic cystectomy trial I Scand J Urol Nephrol 27 1993 355 362
13. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data Eur Urol 48 2005 202 205
14. G. Sonpavde, B.H. Goldman, V.O. Speights, and et al. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy Cancer 115 2009 4104 4109
15. T.A. Splinter, H.I. Scher, L. Denis, and et al. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer - Genitourinary Group J Urol 147 1992 606 608
16. R. Montironi, and A. Lopez-Beltran The 2004 WHO classification of bladder tumors: a summary and commentary Int J Surg Pathol 13 2005 143 153
17. G.V. Raj, S. Karavadia, B. Schlomer, and et al. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Cancer 117 2011 276 282
18. S. Rehman, A. Crane, R. Din, and et al. Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer Urology 82 2013 1370 1375
19. R. Rosenblatt, A. Sherif, E. Rintala, and et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer Eur Urol 61 2012 1229 1238
20. E. Scosyrev, E.M. Messing, E. van Wijngaarden, and et al. Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder Cancer 118 2012 72 81
21. E.R. Plimack, J.H. Hoffman-Censits, R. Viterbo, and et al. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity J Clin Oncol 32 2014 1895 1901
22. Plimack ER, Hoffman-Censits JH, Kutikov A, et al. Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients (pts) with muscle-invasive bladder cancer (MIBC): final results of a multicenter phase II study. J Clin Oncol 2014; 32(suppl; abstract 4513):5s.
23. M.D. Galsky, S.K. Pal, S. Chowdhury, and et al. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer Cancer 121 2015 2586 2593
24. P.C. Black, G.A. Brown, H.B. Grossman, and C.P. Dinney Neoadjuvant chemotherapy for bladder cancer World J Urol 24 2006 531 542
25. M.D. Galsky, G.J. Chen, W.K. Oh, and et al. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma Ann Oncol 23 2012 406 410
26. J.L. Gore, J. Lai, C.M. Setodji, M.S. Litwin, and C.S. Saigal Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis Cancer 115 2009 988 996
27. C.J. Logothetis, F.H. Dexeus, C. Chong, and et al. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience J Urol 141 1989 33 37
28. E. Kastritis, M.A. Dimopoulos, N. Antoniou, and et al. The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy Anticancer Res 26 suppl 5b 2006 3865 3869
29. E. Scosyrev, B.W. Ely, E.M. Messing, and et al. Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710) BJU Int 108 2011 693 699
30. M.J. Wasco, S. Daignault, Y. Zhang, and et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection Urology 70 2007 69 74
31. S.H. Culp, R.J. Dickstein, H.B. Grossman, and et al. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy J Urol 191 2014 40 47
32. M.J. Wasco, S. Daignault, D. Bradley, and R.B. Shah Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases Hum Pathol 41 2010 163 171
33. J. Wang, F.W. Wang, C.A. Lagrange, G.P. Hemstreet III, and A. Kessinger Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases Sarcoma 2010 2010 1 7
34. N. Lagwinski, A. Thomas, A.J. Stephenson, and et al. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases Am J Surg Pathol 31 2007 1777 1787
35. A.M. Kamat, C.P. Dinney, J.R. Gee, and et al. Micropapillary bladder cancer: a review of the University of Texas M.D. Anderson Cancer Center experience with 100 consecutive patients Cancer 110 2007 62 67